UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 10, 2008
ARCH CHEMICALS, INC.
(Exact name of registrant as specified in its charter)
| | | | |
| Virginia | | 1-14601 | | 06-1526315 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | |
| 501 Merritt 7, Norwalk, CT | | 06851 |
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (203) 229-2900
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
INFORMATION TO BE INCLUDED IN THE REPORT
| ITEM 2.02. | RESULTS OF OPERATIONS AND FINANCIAL CONDITION |
On November 10, 2008, Arch Chemicals, Inc. (the “Company”) released the results of operations and financial condition for the three and nine months ended September 30, 2008. Attached as Exhibit 99, and incorporated herein by reference, is a copy of the Company’s earnings press release dated November 10, 2008.
Included in Exhibit 99 are references to the Company’s income and earnings per share from continuing operations which, in some cases, as noted in such Exhibit, exclude the effects of the restructuring, the impact of the change in the U.K. tax rate related to the Company’s U.K. pension plans and the impact of the increase in the Company’s stock price on compensation expense related to the Company’s share-based compensation programs recorded during the three months ended September 30, 2007. Additionally, there are references to the Company’s 2008 full year estimate of diluted income per share from continuing operations which in some cases as noted in such Exhibit, exclude the effects of a pension settlement associated with severance recorded in 2007. Reconciliations of these non-GAAP financial measures to what the Company believes is the most directly comparable U.S. GAAP financial measures are provided in such Exhibit. The Company believes that these non-GAAP financial measures provide comparative information to the earnings guidance that was provided on July 31, 2008 by the Company as well as comparison of results to prior year and therefore are useful to the investment community.
2
| ITEM 9.01. | FINANCIAL STATEMENTS AND EXHIBITS |
(d) Exhibits
| | |
| 99. | | Press Release, dated November 10, 2008. |
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 10, 2008
| | |
| ARCH CHEMICALS, INC. |
| |
| By: | | /s/ Steven C. Giuliano |
| Name: | | Steven C. Giuliano |
| Title: | | Vice President and Chief Financial Officer |
4
Exhibit Index
| | |
Exhibit No. | | Description |
99. | | Press Release, dated November 10, 2008. |
5
